Cyanomethyl Vinyl Ethers Against Naegleria fowleri

Naegleria fowleri is a pathogenic amoeba that causes a fulminant and rapidly progressive disease affecting the central nervous system called primary amoebic meningoencephalitis (PAM). Moreover, the disease is fatal in more than 97% of the reported cases, mostly affecting children and young people after practicing aquatic activities in nontreated fresh and warm water bodies contaminated with these amoebae. Currently, the treatment of primary amoebic meningoencephalitis is based on a combination of different antibiotics and antifungals, which are not entirely effective and lead to numerous side effects. In the recent years, research against PAM is focused on the search of novel, less toxic, and fully effective antiamoebic agents. Previous studies have reported the activity of cyano-substituted molecules in different protozoa. Therefore, the activity of 46 novel synthetic cyanomethyl vinyl ethers (QOET-51 to QOET-96) against two type strains of N. fowleri (ATCC 30808 and ATCC 30215) was determined. The data showed that QOET-51, QOET-59, QOET-64, QOET-67, QOET-72, QOET-77, and QOET-79 were the most active molecules. In fact, the selectivity index (CC50/IC50) was sixfold higher when compared to the activities of the drugs of reference. In addition, the mechanism of action of these compounds was studied, with the aim to demonstrate the induction of a programmed cell death process in N. fowleri.

[1]  J. Štursa,et al.  The 4-Aminomethylphenoxy-Benzoxaborole AN3057 as a Potential Treatment Option for Primary Amoebic Meningoencephalitis , 2023, Antimicrobial agents and chemotherapy.

[2]  Dattatreya Mukherjee,et al.  Increasing cases of Naegleria fowleri during the time of COVID 19; an emerging concern of Pakistan , 2022, International Journal of Surgery.

[3]  J. Lorenzo-Morales,et al.  A Fluorometric Assay for the In Vitro Evaluation of Activity against Naegleria fowleri Cysts , 2022, Microbiology spectrum.

[4]  Yibin Zhao,et al.  Factors influencing the blood-brain barrier permeability , 2022, Brain Research.

[5]  J. Lorenzo-Morales,et al.  Cyclolauranes as plausible chemical scaffold against Naegleria fowleri. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  J. Lorenzo-Morales,et al.  Sesquiterpene lactones as potential therapeutic agents against Naegleria fowleri. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[7]  J. Lorenzo-Morales,et al.  Statins Induce Actin Cytoskeleton Disassembly and an Apoptosis-Like Process in Acanthamoeba spp. , 2022, Antibiotics.

[8]  Yanyan Zhang,et al.  A pediatric case of primary amoebic meningoencephalitis due to Naegleria fowleri diagnosed by next-generation sequencing of cerebrospinal fluid and blood samples , 2021, BMC Infectious Diseases.

[9]  J. Lorenzo-Morales,et al.  The therapeutic potential of novel isobenzofuranones against Naegleria fowleri , 2021, International journal for parasitology. Drugs and drug resistance.

[10]  A. Güémez,et al.  Primary Amoebic Meningoencephalitis by Naegleria fowleri: Pathogenesis and Treatments , 2021, Biomolecules.

[11]  D. Tejedor,et al.  Cyanovinylation of Aldehydes: Organocatalytic Multicomponent Synthesis of Conjugated Cyanomethyl Vinyl Ethers , 2021, Molecules.

[12]  A. Debnath,et al.  Activity of Auranofin against Multiple Genotypes of Naegleria fowleri and its Synergistic Effect with Amphotericin B in vitro. , 2020, ACS chemical neuroscience.

[13]  Jose E Piñero,et al.  Naegleria fowleri , 2020, Definitions.

[14]  M. Akram,et al.  Naegleria fowleri: Sources of infection, pathophysiology, diagnosis, and management; a review , 2019, Clinical and experimental pharmacology & physiology.

[15]  J. Lorenzo-Morales,et al.  Isolation of Naegleria spp. from a Brazilian Water Source , 2019, Pathogens.

[16]  J. Lorenzo-Morales,et al.  Is Naegleria fowleri an Emerging Parasite? , 2019, Trends in parasitology.

[17]  A. López-Arencibia,et al.  In Vitro Activity of Statins against Naegleria fowleri , 2019, Pathogens.

[18]  R. Docampo,et al.  Further insights of selenium-containing analogues of WC-9 against Trypanosoma cruzi. , 2019, Bioorganic & medicinal chemistry.

[19]  D. Kyle,et al.  Phenotypic Screens Reveal Posaconazole as a Rapidly Acting Amebicidal Combination Partner for Treatment of Primary Amoebic Meningoencephalitis , 2018, The Journal of infectious diseases.

[20]  S. Sherchan,et al.  Comparison of next‐generation droplet digital PCR with quantitative PCR for enumeration of Naegleria fowleri in environmental water and clinical samples , 2018, Letters in applied microbiology.

[21]  Humera Anser,et al.  A Review on Global Distribution of Primary Amoebic Meningoencephalitis (PAM) Caused By Naegleria Fowleri- The Brain Eating Amoeba , 2018 .

[22]  O. Thiemann,et al.  The therapeutic strategies against Naegleria fowleri. , 2018, Experimental parasitology.

[23]  J. Mehal,et al.  Estimation of Undiagnosed Naegleria fowleri Primary Amebic Meningoencephalitis, United States , 2018, Emerging infectious diseases.

[24]  J. Lorenzo-Morales,et al.  Molecular identification of waterborne free living amoebae (Acanthamoeba, Naegleria and Vermamoeba) isolated from municipal drinking water and environmental sources, Semnan province, north half of Iran. , 2017, Experimental parasitology.

[25]  M. Shibayama,et al.  Amphotericin B induces apoptosis-like programmed cell death in Naegleria fowleri and Naegleria gruberi. , 2017, Microbiology.

[26]  R. Siddiqui,et al.  Biology and pathogenesis of Naegleria fowleri. , 2016, Acta tropica.

[27]  A. Baig.  Primary Amoebic Meningoencephalitis: Neurochemotaxis and Neurotropic Preferences of Naegleria fowleri. , 2016, ACS chemical neuroscience.

[28]  A. Harris,et al.  Diagnosis, Clinical Course, and Treatment of Primary Amoebic Meningoencephalitis in the United States, 1937-2013. , 2015, Journal of the Pediatric Infectious Diseases Society.

[29]  Kristopher G. Virga,et al.  Naegleria fowleri: Pathogenesis, Diagnosis, and Treatment Options , 2015, Antimicrobial Agents and Chemotherapy.

[30]  I. Morel,et al.  Amatoxins (α- and β-Amanitin) and phallotoxin (Phalloidin) analyses in urines using high-resolution accurate mass LC-MS technology. , 2014, Journal of analytical toxicology.

[31]  Jeremy C. Mottram,et al.  Cell death in parasitic protozoa: regulated or incidental? , 2012, Nature Reviews Microbiology.

[32]  Szymon Kaczanowski,et al.  Evolution of apoptosis-like programmed cell death in unicellular protozoan parasites , 2011, Parasites & Vectors.

[33]  R. Villar,et al.  Heterocyclic-2-carboxylic Acid (3-Cyano-1,4-di-N-oxidequinoxalin-2-yl)amide Derivatives as Hits for the Development of Neglected Disease Drugs , 2009, Molecules.

[34]  F. Schuster,et al.  Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. , 2007, FEMS immunology and medical microbiology.

[35]  C. Thompson,et al.  Death by design: apoptosis, necrosis and autophagy. , 2004, Current opinion in cell biology.

[36]  F. Schuster,et al.  Balamuthia mandrillaris from soil samples. , 2004, Microbiology.

[37]  R. Bharath,et al.  Primary Meningoencephalitis by Naegleria fowleri: First Reported Case from Mangalore, South India , 2002, Journal of Clinical Microbiology.

[38]  Martin Schuler,et al.  Cytochrome C Maintains Mitochondrial Transmembrane Potential and Atp Generation after Outer Mitochondrial Membrane Permeabilization during the Apoptotic Process , 2001, The Journal of cell biology.

[39]  T. Pollard,et al.  Kinetics and thermodynamics of phalloidin binding to actin filaments from three divergent species. , 1996, Biochemistry.

[40]  J. Klán.  [A review of mushrooms containing amanitins and phalloidines]. , 1993, Casopis lekaru ceskych.

[41]  C. Gicquaud,et al.  Effect of phalloidin and viroisin on Acanthamoeba castellanii after permeabilization of the cell. , 1987, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[42]  R. K. Robins,et al.  Synthesis and biological activity of certain 3,4-disubstituted pyrazolo[3,4-d]pyrimidine nucleosides. , 1984, Journal of medicinal chemistry.

[43]  R. Duma,et al.  In Vitro Susceptibility of Pathogenic Naegleria and Acanthamoeba Species to a Variety of Therapeutic Agents , 1976, Antimicrobial Agents and Chemotherapy.

[44]  F. Schuster,et al.  In Vitro Effects of Amphotericin B on Growth and Ultrastructure of the Amoeboflagellates Naegleria gruberi and Naegleria fowleri , 1975, Antimicrobial Agents and Chemotherapy.

[45]  W. Rosenblum,et al.  Primary amoebic meningoencephalitis caused by Naegleria. Two new cases, response to amphotericin B, and a review. , 1971, Annals of internal medicine.

[46]  Sonali K Kalra,et al.  Acanthamoeba and its pathogenic role in granulomatous amebic encephalitis. , 2019, Experimental parasitology.

[47]  J. Błaszkowska,et al.  Neuroinvasions caused by parasites , 2017, Annals of parasitology.

[48]  J. D. de Jonckheere.  Origin and evolution of the worldwide distributed pathogenic amoeboflagellate Naegleria fowleri. , 2011, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[49]  L. Deodhar,et al.  Isolation and identification of pathogenic Naegleria fowleri (aerobia) from a swimming pool in Bombay. , 1985, Transactions of the Royal Society of Tropical Medicine and Hygiene.